Hospira Atracurium Besilate 10 mg/mL Injection 250 mg/25 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira atracurium besilate 10 mg/ml injection 250 mg/25 ml vial

hospira australia pty ltd - atracurium besilate, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - atracurium besilate injection is indicated as an adjunct to general anaesthesia during surgery to relax skeletal muscles, and to facilitate endotracheal intubation and mechanical ventilation. it is also indicated to facilitate mechanical ventilation in intensive care unit (icu) patients.

Hospira Methotrexate 100 mg/mL Injection 1 g/10 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira methotrexate 100 mg/ml injection 1 g/10 ml vial

hospira australia pty ltd - methotrexate, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - united kingdom: methotrexate injection is an anti-metabolite medicine and immunosuppressant. it is used in large doses to treat certain types of cancer such as breast cancer. in smaller doses it can be used to treat severe psoriasis, when it has not responded to other treatments. ireland: methotrexate is used to treat cancer, such as: lymphatic leukemia (disease of the blood or bone marrow), breast cancer, bone cancer, head and neck cancer, gynaecologic cancer (choriocarcinoma, trophoblastic disease ? tumor development directly associated with pregnancy), and non-hodgkin?s lymphoma. methotrexate can also be used to treat severe psoriasis, when it has not responded to other treatments.

Hospira Vincristine Sulfate Injection USP 2 mg/2 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira vincristine sulfate injection usp 2 mg/2 ml vial

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: water for injections; mannitol; sodium hydroxide; sulfuric acid - vincristine sulfate injection is indicated in acute leukemia. vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin's disease, non-hodgkin's malignant lymphomas (lymphocytic, mixed cell, histiocytic, undifferentiated, nodular and diffuse types), rhabdomyosarcoma, neuroblastoma, and wilm's tumor.